Cleared Abbreviated

K012139 - VAMOS ANESTHETIC GAS MONITOR

K012139 is an FDA 510(k) clearance for VAMOS ANESTHETIC GAS MONITOR, manufactured by Draeger Medical, Inc.. The device is a Class 2 Anesthesiology device with product code CCK cleared through the Abbreviated 510(k) pathway after a 191-day FDA review.

K012139 · Draeger Medical, Inc. · Anesthesiology device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Jan 2002
Decision
191d
Days
Class 2
Risk

K012139 is an FDA 510(k) clearance for the VAMOS ANESTHETIC GAS MONITOR. Classified as Analyzer, Gas, Carbon-dioxide, Gaseous-phase (product code CCK), Class II - Special Controls.

Submitted by Draeger Medical, Inc. (Telford, US). The FDA issued a Cleared decision on January 17, 2002 after a review of 191 days - an extended review cycle.

This device falls under the Anesthesiology FDA review panel, regulated under 21 CFR 868.1400 - the FDA anesthesiology and respiratory device framework. The Abbreviated 510(k) pathway was used, relying on FDA-recognized standards to demonstrate substantial equivalence.

Device pattern: Standards-based predicate clearance. Standards-verified equivalence. The Abbreviated pathway signals strong alignment with FDA-recognized performance standards - typically associated with lower review burden and faster clearance cycles.

View all Draeger Medical, Inc. devices

FDA 510(k) Submission Details - K012139

510(k) Number K012139 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received July 10, 2001
Decision Date January 17, 2002
Days to Decision 191 days
Submission Type Abbreviated
Review Panel Anesthesiology (AN)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
51d slower than avg
Panel avg: 140d · This submission: 191d
Pathway characteristics
Standards-based clearance path.

CCK Device Classification - Class 2, Special Controls

Product Code CCK Analyzer, Gas, Carbon-dioxide, Gaseous-phase
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 868.1400
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Anesthesiology devices follow this clearance model.

Regulatory Peers - CCK Analyzer, Gas, Carbon-dioxide, Gaseous-phase

All 248
Devices cleared under the same product code (CCK) and FDA review panel - the closest regulatory comparables to K012139.
MERCURY MEDICAL STATCO2 END TIDAL CO2 DETECTOR, MODEL 10-55370
K021576 · Mercury Medical · Nov 2002
MULTIGAS UNIT, MODEL AG-920RA
K020046 · Nihon Kohden America, Inc. · Jul 2002
OXYARM CO2
K014211 · Southmedic, Inc. · Jun 2002
MODIFICATION TO: MAC-LINE O2/CO2 ORAL NASAL CANNULA SAMPLE LINE
K013845 · Oridion Medical 1987 , Ltd. · Nov 2001
MICROSTREAM O2/CO2 ORAL NASAL FILTERLINE
K011536 · Oridion Medical 1987 , Ltd. · Nov 2001
MAC-LINE CO2 NASAL CANNULA SAMPLE LINE
K012391 · Oridion Medical 1987 , Ltd. · Aug 2001